email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
481 - 495
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Simcere to Test TNRF2 mAb in Combination with MSD’s Keytruda for Solid Tumors
$5.00
Available
Everest’s In-licensed Kidney Drug Meets Endpoints in Phase III Trial
$5.00
Available
Bio-Thera Starts Phase I Trial of Nectin-4 ADC for Solid Tumors
$5.00
Available
Livzon Acquires Rights to GERD Therapy from Onconic for $127.5 Million
$5.00
Available
Luye Enrolls Last Patient in Phase III Trial of Eylea Biosimilar
$5.00
Available
Allorion Raises $50 Million for Oncology/Autoimmune Precision Medicines
$5.00
Available
AusperBio Starts New Zealand Phase I Trial of Novel Therapy for CHB
$5.00
Available
Ambrx Partner Says HER2 ADC Ups Progression-Free Survival in Breast Cancer Trial
$5.00
Available
Ractigen Granted Orphan Drug Status for Use of Novel siRNA in ALS
$5.00
Available
CFIUS Approves Sino Biopharm’s Acquisition of F-Star after Nine Month Wait
$5.00
Available
Rinua Gene Raises $14.5 Million in Pre-A+ Round for mRNA Drugs
$5.00
Available
Harbour BioMed mAb Posts Positive Results in Phase III Myasthenia Gravis Trial
$5.00
Available
JW Therapeutics Starts China Trial of T-cell Immunotherapy for Liver Cancer
$5.00
Available
Transcenta Reports Immuno-PET Diagnoses CLDN18.2 Levels in Gastrointestinal Tumors
$5.00
Available
Abbisko Out-Licenses Precision EGFR-TKI Medicine to Allist in $188 Million Deal
$5.00
Available